Cargando…

Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms

The natural xanthone α-mangostin (αM) exhibits a wide range of pharmacological activities, including antineoplastic and anti-nematode properties, but low water solubility and poor selectivity of the drug prevent its potential clinical use. Therefore, the targeted third-generation poly(amidoamine) de...

Descripción completa

Detalles Bibliográficos
Autores principales: Markowicz, Joanna, Uram, Łukasz, Wołowiec, Stanisław, Rode, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657743/
https://www.ncbi.nlm.nih.gov/pubmed/34884739
http://dx.doi.org/10.3390/ijms222312925
_version_ 1784612571741945856
author Markowicz, Joanna
Uram, Łukasz
Wołowiec, Stanisław
Rode, Wojciech
author_facet Markowicz, Joanna
Uram, Łukasz
Wołowiec, Stanisław
Rode, Wojciech
author_sort Markowicz, Joanna
collection PubMed
description The natural xanthone α-mangostin (αM) exhibits a wide range of pharmacological activities, including antineoplastic and anti-nematode properties, but low water solubility and poor selectivity of the drug prevent its potential clinical use. Therefore, the targeted third-generation poly(amidoamine) dendrimer (PAMAM G3) delivery system was proposed, based on hyperbranched polymer showing good solubility, high biocompatibility and low immunogenicity. A multifunctional nanocarrier was prepared by attaching αM to the surface amine groups of dendrimer via amide bond in the ratio 5 (G3(2B12gh5M)) or 17 (G3(2B10gh17M)) residues per one dendrimer molecule. Twelve or ten remaining amine groups were modified by conjugation with D-glucoheptono-1,4-lactone (gh) to block the amine groups, and two biotin (B) residues as targeting moieties. The biological activity of the obtained conjugates was studied in vitro on glioma U-118 MG and squamous cell carcinoma SCC-15 cancer cells compared to normal fibroblasts (BJ), and in vivo on a model organism Caenorhabditis elegans. Dendrimer vehicle G3(2B12gh) at concentrations up to 20 µM showed no anti-proliferative effect against tested cell lines, with a feeble cytotoxicity of the highest concentration seen only with SCC-15 cells. The attachment of αM to the vehicle significantly increased cytotoxic effect of the drug, even by 4- and 25-fold for G3(2B12gh5M) and G3(2B10gh17M), respectively. A stronger inhibition of cells viability and influence on other metabolic parameters (proliferation, adhesion, ATP level and Caspase-3/7 activity) was observed for G3(2B10gh17M) than for G3(2B12gh5M). Both bioconjugates were internalized efficiently into the cells. Similarly, the attachment of αM to the dendrimer vehicle increased its toxicity for C. elegans. Thus, the proposed α-mangostin delivery system allowed the drug to be more effective in the dendrimer-bound as compared to free state against both cultured the cancer cells and model organism, suggesting that this treatment is promising for anticancer as well as anti-nematode chemotherapy.
format Online
Article
Text
id pubmed-8657743
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86577432021-12-10 Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms Markowicz, Joanna Uram, Łukasz Wołowiec, Stanisław Rode, Wojciech Int J Mol Sci Article The natural xanthone α-mangostin (αM) exhibits a wide range of pharmacological activities, including antineoplastic and anti-nematode properties, but low water solubility and poor selectivity of the drug prevent its potential clinical use. Therefore, the targeted third-generation poly(amidoamine) dendrimer (PAMAM G3) delivery system was proposed, based on hyperbranched polymer showing good solubility, high biocompatibility and low immunogenicity. A multifunctional nanocarrier was prepared by attaching αM to the surface amine groups of dendrimer via amide bond in the ratio 5 (G3(2B12gh5M)) or 17 (G3(2B10gh17M)) residues per one dendrimer molecule. Twelve or ten remaining amine groups were modified by conjugation with D-glucoheptono-1,4-lactone (gh) to block the amine groups, and two biotin (B) residues as targeting moieties. The biological activity of the obtained conjugates was studied in vitro on glioma U-118 MG and squamous cell carcinoma SCC-15 cancer cells compared to normal fibroblasts (BJ), and in vivo on a model organism Caenorhabditis elegans. Dendrimer vehicle G3(2B12gh) at concentrations up to 20 µM showed no anti-proliferative effect against tested cell lines, with a feeble cytotoxicity of the highest concentration seen only with SCC-15 cells. The attachment of αM to the vehicle significantly increased cytotoxic effect of the drug, even by 4- and 25-fold for G3(2B12gh5M) and G3(2B10gh17M), respectively. A stronger inhibition of cells viability and influence on other metabolic parameters (proliferation, adhesion, ATP level and Caspase-3/7 activity) was observed for G3(2B10gh17M) than for G3(2B12gh5M). Both bioconjugates were internalized efficiently into the cells. Similarly, the attachment of αM to the dendrimer vehicle increased its toxicity for C. elegans. Thus, the proposed α-mangostin delivery system allowed the drug to be more effective in the dendrimer-bound as compared to free state against both cultured the cancer cells and model organism, suggesting that this treatment is promising for anticancer as well as anti-nematode chemotherapy. MDPI 2021-11-29 /pmc/articles/PMC8657743/ /pubmed/34884739 http://dx.doi.org/10.3390/ijms222312925 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Markowicz, Joanna
Uram, Łukasz
Wołowiec, Stanisław
Rode, Wojciech
Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms
title Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms
title_full Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms
title_fullStr Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms
title_full_unstemmed Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms
title_short Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms
title_sort biotin transport-targeting polysaccharide-modified pamam g3 dendrimer as system delivering α-mangostin into cancer cells and c. elegans worms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657743/
https://www.ncbi.nlm.nih.gov/pubmed/34884739
http://dx.doi.org/10.3390/ijms222312925
work_keys_str_mv AT markowiczjoanna biotintransporttargetingpolysaccharidemodifiedpamamg3dendrimerassystemdeliveringamangostinintocancercellsandcelegansworms
AT uramłukasz biotintransporttargetingpolysaccharidemodifiedpamamg3dendrimerassystemdeliveringamangostinintocancercellsandcelegansworms
AT wołowiecstanisław biotintransporttargetingpolysaccharidemodifiedpamamg3dendrimerassystemdeliveringamangostinintocancercellsandcelegansworms
AT rodewojciech biotintransporttargetingpolysaccharidemodifiedpamamg3dendrimerassystemdeliveringamangostinintocancercellsandcelegansworms